Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients

Clinical trial NCT05968118 · UNKNOWN

Trial details

NCT number: NCT05968118
Sponsor: Beijing Northland Biotech. Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Artery Disease

Start date: 2022-07-29
Primary completion: 2023-07-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.